Glaukos
GKOS
$99.48
Share price
-0.63%
Change (1 day)
109.39%
Change (1 year)
Categories
Glaukos (GKOS) - Cash on Hand
Cash on Hand as of December 2023 : $0.29 B
According to Glaukos's latest financial reports the company has $0.29 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Glaukos - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.29 B | -16.24% |
| 2022-12-31 | $0.35 B | -14.82% |
| 2021-12-31 | $0.41 B | 2.39% |
| 2020-12-31 | $0.40 B | 132.42% |
| 2019-12-31 | $0.17 B | 23.84% |
| 2018-12-31 | $0.14 B | 18.04% |
| 2017-12-31 | $0.11 B | 24.28% |
| 2016-12-31 | $95.76 M | 5.09% |
| 2015-12-31 | $91.12 M | 3855.03% |
| 2014-12-31 | $2.3 M | -65.76% |
| 2013-12-31 | $6.72 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ICU Medical
ICUI | $0.25 B | -13.78% | 🇺🇸 USA |
 AtriCure ATRC | $0.13 B | -53.53% | 🇺🇸 USA |
 Integra LifeSciences IART | $0.30 B | 4.63% | 🇺🇸 USA |
 Hill-Rom HRC | N/A | N/A | 🇺🇸 USA |